Review

[Nature Reviews Urology] Scientists summarize the current evidence indicating that aberrant or dysregulated N6‐methyladenosine (m6A) modification is associated with urological cancer development, progression and prognosis.

[Life Sciences] The authors illustrate the enormous potential of novel synergistic therapeutic strategies and the targeted nanoparticles as an alternate strategy for t treating a variety of tumors employing antiangiogenic therapy.

[Molecular Neurobiology] Mitochondria-Endoplasmic Reticulum Contact Sites (MERCS) are dynamic structures whose physiological interaction is vital to direct life and death of the cell. Dysregulation of this interplay leads to various neurodegenerative disorders.

[Nature Communications] Autoimmune disease heritability is enriched in T cell-specific regulatory regions of the genome. Modern-day T cell datasets now enable association studies between single nucleotide polymorphisms and a myriad of molecular phenotypes.

[Journal Of Materials Chemistry B] The pathological features of liver fibrosis and the current anti-fibrosis drugs in clinical trials are briefly introduced, followed by a detailed introduction of the therapeutic nanoagents for the precise delivery of anti-fibrosis drugs.

[Blood Cancer Journal] Despite recent advances in frontline therapy for diffuse large B-cell lymphoma (DLBCL), at least a third of those diagnosed still will require second or further lines for relapsed or refractory disease.